**Core Concept**
Quinine-induced thrombocytopenia is a rare but serious side effect of quinine therapy, characterized by the development of autoantibodies against platelet glycoproteins. This leads to platelet destruction and a subsequent decrease in platelet count.

**Why the Correct Answer is Right**
The mechanism behind quinine-induced thrombocytopenia involves the formation of autoantibodies against platelet glycoproteins, specifically GPIIb/IIIa. These autoantibodies are formed due to the binding of quinine to platelets, which exposes cryptic epitopes on the glycoproteins. This binding of autoantibodies to the glycoproteins on the platelet surface leads to platelet activation, aggregation, and eventual destruction by the immune system.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the underlying mechanism of quinine-induced thrombocytopenia. While it may be a plausible answer, it lacks the specific detail required to accurately describe the condition.

**Option B:** This option is incorrect because it does not accurately describe the pathophysiology of quinine-induced thrombocytopenia. While platelet transfusions may be used to manage the condition, they do not address the underlying cause of the thrombocytopenia.

**Option C:** This option is incorrect because it does not mention the specific glycoproteins involved in quinine-induced thrombocytopenia. While it may be a relevant aspect of platelet biology, it does not accurately describe the condition.

**Clinical Pearl / High-Yield Fact**
The use of quinine in patients with a history of thrombocytopenia or those receiving anticoagulant therapy should be approached with caution, as it may exacerbate the condition. Additionally, patients treated with quinine should be monitored closely for signs of thrombocytopenia, including bruising, petechiae, and bleeding.

**Correct Answer:** B. Quinine-induced thrombocytopenia is managed with platelet transfusions and the discontinuation of quinine therapy.